Zomedica (ZOMDF) Gross Margin (2021 - 2026)
Zomedica (ZOMDF) recorded Gross Margin of 61.06% in Q3 2026, down 6.10 percentage points from 67.15% a year earlier and down 2.45 percentage points from the prior quarter.
Powered by 
Analysis
Zomedica (ZOMDF) Gross Margin (2021 - 2026) Analysis & Trends
On a TTM basis, Zomedica's Gross Margin came in at 63.96% as of Sep 30, 2026, down 4.14 percentage points year-over-year; for FY2025, it came in at 67.68%, down 2.27 percentage points from FY2024.
- Annual Gross Margin has a four-year change of -6.21 percentage points (FY2021 to FY2025).
- Across earlier years, Gross Margin came in at 69.95% in FY2024 (+1.19 pp), 68.76% in FY2023 (-2.39 pp), 71.15% in FY2022 (-2.75 pp) and 73.89% in FY2021.
- The Q3 2026 figure is the lowest quarterly Gross Margin since Q3 2021.
- On a year-over-year basis, Gross Margin has declined for six consecutive quarters, with an average year-over-year change of -2.87 percentage points over the last eight quarters.
- Peak year-over-year performance for Gross Margin in the last five years was a gain of 195.80 percentage points in Q2 2022, against a drop of 6.61 percentage points in Q4 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at 63.51% (Q2 2026), 62.33% (Q1 2026) and 68.47% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 83.88% |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 68.12% |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 75.38% |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 72.95% |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 88.03% |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 73.10% |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 81.07% |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 75.71% |
| 10 | Zomedica | 97.99 Mn | -87.03 Mn | 6.04 Mn | 61.06% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 61.06% |
| Jun 30, 2026 | 63.51% |
| Mar 31, 2026 | 62.33% |
| Dec 31, 2025 | 68.47% |
| Sep 30, 2025 | 67.15% |
| Jun 30, 2025 | 67.00% |
| Mar 31, 2025 | 67.80% |
| Dec 31, 2024 | 70.27% |
| Sep 30, 2024 | 72.32% |
| Jun 30, 2024 | 71.15% |
| Mar 31, 2024 | 65.75% |
| Dec 31, 2023 | 69.14% |
| Sep 30, 2023 | 68.73% |
| Jun 30, 2023 | 67.24% |
| Mar 31, 2023 | 69.96% |
| Dec 31, 2022 | 68.39% |
| Sep 30, 2022 | 73.51% |
| Jun 30, 2022 | 70.80% |
| Mar 31, 2022 | 73.05% |
| Dec 31, 2021 | 75.01% |
API Access
Zomedica Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=ZOMDF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "ZOMDF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=ZOMDF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();